nevirapine has been researched along with Acute Disease in 5 studies
Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.
Acute Disease: Disease having a short and relatively severe course.
| Excerpt | Relevance | Reference |
|---|---|---|
| "At the defined period, 306 patients started a nevirapine-containing regimen, of whom eight developed an acute hepatitis (2." | 7.72 | Case series of acute hepatitis in a non-selected group of HIV-infected patients on nevirapine-containing antiretroviral treatment. ( Beijnen, JH; de Maat, MM; Mairuhu, AT; Mulder, JW; ter Heine, R; van Gorp, EC, 2003) |
| "In a setting of high perinatal nevirapine use, acute chorioamnionitis was not associated with vertical HIV-1 transmission." | 5.12 | Acute and chronic chorioamnionitis and the risk of perinatal human immunodeficiency virus-1 transmission. ( Chi, BH; Goldenberg, RL; Levy, J; Mudenda, V; Sinkala, M; Stringer, JS, 2006) |
| "At the defined period, 306 patients started a nevirapine-containing regimen, of whom eight developed an acute hepatitis (2." | 3.72 | Case series of acute hepatitis in a non-selected group of HIV-infected patients on nevirapine-containing antiretroviral treatment. ( Beijnen, JH; de Maat, MM; Mairuhu, AT; Mulder, JW; ter Heine, R; van Gorp, EC, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Maat, MM | 1 |
| ter Heine, R | 1 |
| van Gorp, EC | 1 |
| Mulder, JW | 1 |
| Mairuhu, AT | 1 |
| Beijnen, JH | 1 |
| Weissbrich, B | 1 |
| Langmann, P | 1 |
| Schubert, J | 1 |
| Jassoy, C | 1 |
| Klinker, H | 1 |
| Zala, C | 1 |
| Salomón, H | 1 |
| Cahn, P | 1 |
| Chi, BH | 1 |
| Mudenda, V | 1 |
| Levy, J | 1 |
| Sinkala, M | 1 |
| Goldenberg, RL | 1 |
| Stringer, JS | 1 |
| Gottlieb, S | 1 |
1 trial available for nevirapine and Acute Disease
| Article | Year |
|---|---|
Acute and chronic chorioamnionitis and the risk of perinatal human immunodeficiency virus-1 transmission.
Topics: Acute Disease; Adult; Anti-HIV Agents; Chorioamnionitis; Chronic Disease; Female; Fetal Blood; HIV I | 2006 |
4 other studies available for nevirapine and Acute Disease
| Article | Year |
|---|---|
Case series of acute hepatitis in a non-selected group of HIV-infected patients on nevirapine-containing antiretroviral treatment.
Topics: Acute Disease; Adult; Anti-HIV Agents; Anti-Retroviral Agents; Drug Therapy, Combination; Female; He | 2003 |
Resolution of HCV infection in a HIV-infected patient under HAART after several hepatitis flare-ups.
Topics: Acute Disease; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Hepatitis C, Chronic; | 2003 |
Treatment of primary HIV infection: a pilot study of stavudine and didanosine plus nevirapine with or without hydroxyurea.
Topics: Acute Disease; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; Enzyme | 1999 |
Nevirapine should not be prescribed for needlestick injuries.
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Anti-HIV Agents; Chemical and Drug Induced Liver | 2001 |